Hyperactivity News and Research

RSS

Study points to new therapeutic strategy for treating depression

A new study points to a conceptually novel therapeutic strategy for treating depression. Instead of dampening neuron firing found with stress-induced depression, researchers demonstrated for the first time that further activating these neurons opens a new avenue to mimic and promote natural resilience.

21 Apr 2014

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Children with Tourette Syndrome (TS) may unconsciously train their brain to more effectively control their tics.

17 Apr 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.

15 Apr 2014

Study confirms neurobiological origin of attention-deficit disorder

A study, carried out on mice, has just confirmed the neurobiological origin of attention-deficit disorder (ADD), a syndrome whose causes are poorly understood. Researchers from CNRS, the University of Strasbourg and INSERM1 have identified a cerebral structure, the superior colliculus, where hyperstimulation causes behavior modifications similar to those of some patients who suffer from ADD.

11 Apr 2014

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

Neurovance, Inc. today announced that it has closed a $6.3 million extension to its series A1 financing round to further advance development of EB-1020 SR, a non-stimulant, for the treatment of all subtypes of adult ADHD (attention deficit hyperactivity disorder).

3 Apr 2014

FDA clears QbTest for unbiased evaluation of ADHD treatment

The US Food and Drug Administration (FDA) has cleared the neuropsychological test - QbTest - developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD.

2 Apr 2014

NeuroSigma gets approval to market Monarch eTNS System in Australia

NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.

1 Apr 2014

Study finds effectiveness of brief behavioral and mental health programs in pediatric practices

Brief behavioral and mental health programs for children can be effectively provided within pediatric practices as an alternative to being referred to a community specialist, University of Pittsburgh Schools of the Health Sciences researchers found in a National Institutes of Health-funded randomized trial.

26 Mar 2014

Anxiety relief in children: an interview with Dr. Golda Ginsburg, Johns Hopkins Children’s Center

Anxiety is the most common psychiatric disorder among youth. Prevalence rates hover around 10%, although the actual percent varies depending on the specific anxiety disorder, sample, method of assessment, etc.

24 Mar 2014

Restless legs syndrome alters expression of critical gene during fetal development of brain

In a study published online in Genome Research, researchers of the Helmholtz Zentrum München und the Technische Universität München have demonstrated that a common genetic variant associated with Restless Legs Syndrome (RLS) alters the expression of a critical gene during fetal development of the brain.

19 Mar 2014

Children treated with stimulants for ADHD experienced BMI rebound in late adolescence

A new study from researchers at Johns Hopkins Bloomberg School of Public Health found that children treated with stimulants for attention deficit hyperactivity disorder (ADHD) experienced slower body mass index (BMI) growth than their undiagnosed or untreated peers, followed by a rapid rebound of BMI that exceeded that of children with no history of ADHD or stimulant use and that could continue to obesity.

18 Mar 2014

Research roundup: Medicaid eligibility; tracking discontinued randomized trials; decline in work-based insurance

Under the Affordable Care Act (ACA), changes in income and family circumstances are likely to produce frequent transitions in eligibility for Medicaid and health insurance Marketplace coverage for low- and middle-income adults.

17 Mar 2014

UC Davis MIND Institute named Intellectual and Developmental Disabilities Research Center

The UC Davis MIND Institute has been named an Intellectual and Developmental Disabilities Research Center, through a prestigious grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health - a distinction held by only a handful of neurodevelopmental centers nationwide committed to the diagnosis, prevention, treatment and amelioration of developmental disorders such as autism, fragile X syndrome and Down syndrome.

14 Mar 2014

Children with ASD and ADHD are more likely to exhibit gender variance

John F. Strang, PsyD, a pediatric neuropsychologist at Children's National Health System, and colleagues, found that children with autism spectrum disorders (ASD) or attention deficit hyperactivity disorder (ADHD) were more likely to exhibit gender variance, the wish to be the other gender, than children with no neurodevelopmental disorder, or a medical neurodevelopmental disorder such as epilepsy or neurofibromatosis.

13 Mar 2014

Viewpoints: 'Middlling news' on enrollment; 'secret mandate exemption;' Obama's surprising appearance between two ferns

By the beginning of the month, 4.2 million people had selected a plan. But that doesn't mean they have insurance. Reporters on a conference call asked about the number who had paid, and the administration's representatives said they don't know.

13 Mar 2014

Teenagers with autism spectrum disorder are more likely to wish to be another gender

Children and teenagers with an autism spectrum disorder or those who have attention deficit and hyperactivity problems are much more likely to wish to be another gender.

13 Mar 2014

Research roundup: Health care and prisoners; hospitalized patients' surrogates; suicides in the army

As a group, jail-involved individuals, which we define here as people with a history of arrest and jail admission in the recent past, carry a heavy illness burden, with high rates of infectious and chronic disease as well as mental illness and substance use.

10 Mar 2014

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.

8 Mar 2014

Neuroscientist hopes to paint fuller picture of minds and bodies in Neuroscape lab

How does an autistic child take in information when he sits in a classroom abuzz with social activity? How long does it take someone with multiple sclerosis, which slows activity in the brain, to process the light bouncing off the windshield while she drives?

7 Mar 2014

Study reveals strong association between childhood physical abuse and ADD/ADHD

Thirty percent of adults with Attention Deficit Disorder or Attention Deficit Hyperactivity Disorder (ADD/ADHD) report they were physically abused before they turned 18. This compares to seven per cent of those without ADD/ADHD who were physically abused before 18. The results were in a study published in this week's online Journal of Aggression, Maltreatment, and Trauma.

6 Mar 2014

Hyperactivity News and Research

Study points to new therapeutic strategy for treating depression

Children with Tourette syndrome may unconsciously train brain to effectively control tics

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Study confirms neurobiological origin of attention-deficit disorder

Neurovance closes $6.3M extension to its series A1 financing round to advance development of EB-1020 SR

FDA clears QbTest for unbiased evaluation of ADHD treatment

NeuroSigma gets approval to market Monarch eTNS System in Australia

Study finds effectiveness of brief behavioral and mental health programs in pediatric practices

Anxiety relief in children: an interview with Dr. Golda Ginsburg, Johns Hopkins Children’s Center

Restless legs syndrome alters expression of critical gene during fetal development of brain

Children treated with stimulants for ADHD experienced BMI rebound in late adolescence

Research roundup: Medicaid eligibility; tracking discontinued randomized trials; decline in work-based insurance

UC Davis MIND Institute named Intellectual and Developmental Disabilities Research Center

Children with ASD and ADHD are more likely to exhibit gender variance

Viewpoints: 'Middlling news' on enrollment; 'secret mandate exemption;' Obama's surprising appearance between two ferns

Teenagers with autism spectrum disorder are more likely to wish to be another gender

Research roundup: Health care and prisoners; hospitalized patients' surrogates; suicides in the army

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Neuroscientist hopes to paint fuller picture of minds and bodies in Neuroscape lab

Study reveals strong association between childhood physical abuse and ADD/ADHD

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News